公开(公告)号：US20080083743A1

公开(公告)日：2008-04-10

申请号：US11535218

申请日：2006-09-26

Applicant: Brian Wheeler ,  Joseph Gormley ,  Thomas A. Micka

Inventor： Brian Wheeler ,  Joseph Gormley ,  Thomas A. Micka

IPC: H05B3/02

CPC classification number: A41D31/0038 ,  B32B7/02 ,  H05B3/28 ,  H05B3/342 ,  H05B2203/003 ,  H05B2203/005 ,  H05B2203/013 ,  H05B2203/017 ,  H05B2203/036

Abstract: The invention provides a laminate construction for heating or warming with one or more electrically conductive patterns of conductive ink or paste formed on a first confronting surface of an insulating sheet, where each pattern is connected by one or more conductive elements (bus wires), and where each pattern and the conductive elements are between the confronting surfaces of insulating sheets. The laminate may include one or more stretch and recovery elements to cause the laminate to be more adaptable for securing about any three dimensional body. The laminate with heating elements therein may be incorporated into garments or other wearables or into warming textile structures (pads and blankets).

Abstract translation: 本发明提供了一种用于加热或加热导电油墨或糊状物的导电图案的层压结构，所述导电图案形成在绝缘片的第一相对表面上，其中每个图案通过一个或多个导电元件（母线）连接，以及 其中每个图案和导电元件在绝缘片的相对表面之间。 层压体可以包括一个或多个拉伸和回收元件，以使得层压体更适合于固定在任何三维体上。 其中具有加热元件的层压体可以结合到衣服或其它可穿戴材料中或加入纺织结构（垫和毯子）中。

公开(公告)号：US5733579A

公开(公告)日：1998-03-31

申请号：US417411

申请日：1995-04-05

Applicant: Bryan Warren Wolf ,  Keith Allen Garleb ,  Sheila Martinson Campbell ,  Jonathan Allan Meulbroek ,  Keith Brian Wheeler ,  Joseph Edward Walton

Inventor： Bryan Warren Wolf ,  Keith Allen Garleb ,  Sheila Martinson Campbell ,  Jonathan Allan Meulbroek ,  Keith Brian Wheeler ,  Joseph Edward Walton

IPC: A61K33/14 ,  A61K33/42 ,  A61K31/70

CPC classification number: A61K31/7016 ,  A61K31/702 ,  A61K33/14 ,  Y10S514/867

Abstract: An oral rehydration solution contains indigestible oligosaccharides. Diarrhea related dehydration requires fluid and electrolyte replacement. The primary etiology of antibiotic-associated diarrhea (also known as pseudomembranous colitis) has been recognized as Clostridium difficile. It is believed that the indigenous microflora of a healthy individual suppresses the normally present C. difficile. However, when the indigenous microflora are disrupted (e.g., during antibiotic treatment) overgrowth of C. difficile may occur causing diarrhea and colitis. Treatment of diarrhea related to C. difficile with rehydration therapy and antibiotics has proven effective, but many times relapse occurs. It has been suggested that normalization of the microflora will inhibit C. difficile relapse. Indigestible oligosaccharides have been shown to inhibit C. difficile infection.

Abstract translation: 口服补液溶液含有难消化的寡糖。 腹泻相关脱水需要液体和电解质的更换。 抗生素相关性腹泻（也称为假膜性结肠炎）的主要病因已被认为是艰难梭菌。 据信，健康个体的土着微生物群落抑制了正常存在的艰难梭菌。 然而，当土着微生物群落被破坏时（例如，在抗生素处理期间），可能会发生艰难梭菌的过度生长，导致腹泻和结肠炎。 使用补液治疗和抗生素治疗与艰难梭菌相关的腹泻已被证明是有效的，但多次发生复发。 有人认为微生物群落的正常化会抑制艰难梭菌的复发。 已经显示难消化的寡糖抑制艰难梭菌感染。